Macrophage silica nanoparticle response is phenotypically dependent

Biomaterials

Volumn 53, Issue , 2015, Pages 574-582

  Herd, Heather L ^a,b   Bartlett, Kristopher T ^a,b   Gustafson, Joshua A ^b   McGill, Lawrence D ^c   Ghandehari, Hamidreza ^a,b  

^a University of Utah   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Animal Reference Pathology   (United States)

Author keywords

Drug delivery; Macrophage; Nanoparticles; Silica

Indexed keywords

CELL SIGNALING; CELLS; CYTOLOGY; DRUG DELIVERY; HISTOLOGY; MACROPHAGES; PHYSIOLOGICAL MODELS; SILICA; TISSUE;

CONCENTRATION-DEPENDENT; INFLAMMATORY SIGNALING; MACROPHAGE PHENOTYPES; NANOPARTICLE UPTAKES; PHYSIOLOGICAL RESPONSE; PROLIFERATIVE EFFECTS; RAW 264.7 MACROPHAGES; SILICA NANOPARTICLES;

NANOPARTICLES;

INTERLEUKIN 4; LIPOPOLYSACCHARIDE; SILICA NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; EXPOSURE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; SPLEEN; ANIMAL; CELL LINE; CELL POLARITY; CHEMISTRY; PHYSIOLOGY;

ZIZIPHUS MAURITIANA;

ANIMALS; CELL LINE; CELL POLARITY; MACROPHAGES; MICE; NANOPARTICLES; SILICON DIOXIDE;

EID: 84927939169     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.070     Document Type: Article

References (41)

1. Caron W.P., Lay J.C., Fong A.M., La-Beck N.M., Kumar P., Newman S.E., et al. Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology. JPharmacol Exp Ther 2013, 347:599-606.
2. Caron W.P., Song G., Kumar P., Rawal S., Zamboni W.C. Interpatient pharmacokinetic and pharmacodynamic variability of carrier-mediated anticancer agents. Clin Pharmacol Ther 2012, 91:802-812.
3. Duncan R., Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm 2011, 8:2101-2141.
4. Yang Q., Jones S.W., Parker C.L., Zamboni W.C., Bear J.E., Lai S.K. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. Mol Pharm 2014, 11(4):1250-1258.
5. Mortimer G.M., Butcher N.J., Musumeci A.W., Deng Z.J., Martin D.J., Minchin R.F. Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. ACS Nano 2014, 8(4):3357-3366.
6. Cassetta L., Cassol E., Poli G. Macrophage polarization in health and disease. Scientif World J 2011, 11:2391-2402.
7. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
8. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. JExp Med 1992, 176:287-292.
9. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
10. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997, 18:263-266.
11. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
12. Mantovani A., Sica A., Locati M. Macrophage polarization comes of age. Immunity 2005, 23:344-346.
13. Wang D., Phan N., Isely C., Bruene L., Bratlie K.M. The effect of surface modification and macrophage phenotype on particle internalization. Biomacromolecules 2014, 15(11):4102-4110.
14. Haustein U.-F., Ziegler V., Herrmann K., Mehlhorn J., Schmidt C. Silica-induced scleroderma. JAm Acad Dermatol 1990, 22:444-448.
15. Mohamed B.M., Verma N.K., Davies A.M., McGowan A., Crosbie-Staunton K., Prina-Mello A., et al. Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles invitro and invivo. Nanomedicine (Lond) 2012, 7:1181-1195.
16. Cooper G.S., Miller F.W., Germolec D.R. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002, 2:303-313.
17. Lucarelli M., Gatti A.M., Savarino G., Quattroni P., Martinelli L., Monari E., et al. Innate defense functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Netw 2004, 15:339-346.
18. Schanen B.C., Das S., Reilly C.M., Warren W.L., Self W.T., Seal S., et al. Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles. PloS One 2013, 8. e62816.
19. Jones S.W., Roberts R.A., Robbins G.R., Perry J.L., Kai M.P., Chen K., et al. Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. JClin Invest 2013, 123:3061-3073.
20. Kanchan V., Panda A.K. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 2007, 28:5344-5357.
21. Lutsiak M., Kwon G.S., Samuel J. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. JPharm Pharmacol 2006, 58:739-747.
22. Barbarin V., Xing Z., Delos M., Lison D., Huaux F. Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 2005, 288:L841--L848.
23. Granum B., Gaarder P.I., Groeng E.-C., Leikvold R.-B., Namork E., Løvik M. Fine particles of widely different composition have an adjuvant effect on the production of allergen-specific antibodies. Toxicol Lett 2001, 118:171-181.
24. Kodali V., Littke M.H., Tilton S.C., Teeguarden J.G., Shi L., Frevert C.W., et al. Dysregulation of macrophage activation profiles by engineered nanoparticles. ACS Nano 2013, 7:6997-7010.
25. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micro size range. JColloid Interface Sci 1968, 26:62-69.
26. Blaaderen A., Vrji A. Synthesis and characterization of colloidal dispersions of fluorescent silica spheres. Langmuir 1992, 8:2921-2931.
27. Classen A., Lloberas J., Celada A. Macrophage activation: classical vs. alternative. Macrophages and dendritic cells 2009, 29-43. Springer.
28. Herd H.L., Malugin A., Ghandehari H. Silica nanoconstruct cellular toleration threshold invitro. JControlled Release: Off J Control Release Soc 2011, 153:40-48.
29. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-151.
30. Platt N., Gordon S. Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands. Chem Biol 1998, 5:R193-R203.
31. Chao S.K., Hamilton R.F., Pfau J.C., Holian A. Cell surface regulation of silica-induced apoptosis by the SR-A scavenger receptor in a murine lung macrophage cell line (MH-S). Toxicol Appl Pharmacol 2001, 174:10-16.
32. Hamilton R.F., Thakur S.A., Holian A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med 2008, 44:1246-1258.
33. Malugin A., Ghandehari H. Caspase 3 independent cell death induced by amorphous silica nanoparticles. Nanosci Nanotechnol Lett 2011, 3(3):309-313.
34. Bartneck M., Keul H.A., Wambach M., Bornemann J., Gbureck U., Chatain N., et al. Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells. Nanomed Nanotechnol Biol Med 2012, 8:1282-1292.
35. Yang D., Zhao Y., Guo H., Li Y., Tewary P., Xing G., et al. [Gdat C82 (OH) 22] n nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano 2010, 4:1178-1186.
36. Xu Y., Qian L., Zong G., Ma K., Zhu X., Zhang H., et al. Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization. Neuroscience 2012, 218:35-48.
37. Sindrilaru A., Peters T., Wieschalka S., Baican C., Baican A., Peter H., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. JClin Invest 2011, 121:985.
38. Governa M., Amati M., Fenoglio I., Valentino M., Coloccini S., Bolognini L., et al. Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas. Toxicol Appl Pharmacol 2005, 208:68-77.
39. Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41:14-20.
40. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. JNeurosci 2009, 29:13435-13444.
41. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Multiple Scler J 2011, 17:2-15.